Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.govJingsi Dong, Yonggang Zhang, Yingcai Geng et al.|Frontiers in Oncology|2020Cited by 44
LincRNA00494 Suppresses Non-small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression as a ceRNAJingsi Dong, Qinghua Zhou, Bingjie Li et al.|Frontiers in Oncology|2020Cited by 11
A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC).Ting Wang, Qing Zhou, Li Jiang et al.|Journal of Clinical Oncology|2024Cited by 3
[Current applications of large language models in clinical practice and needs assessment for cardiovascular physicians].W Y Wang, C S, Z X Wang et al.|PubMed|2025Cited by 0